Fortress Biotech, Inc.

FBIONASDAQ • USD
1.99 USD
↘ 0.02 (1.24%)🟢PRE MARKET (AS OF 05:05 AM EST)
🟢Market: OPEN

Fortress Biotech, Inc. (FBIO) trades at $1.99 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (63.0%) and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest FBIO is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 11, 2026.

Open?$1.99
High?$1.99
Low?$1.99
Prev. Close?$2.01
Volume?2
Avg. Volume?234.1K
VWAP?$1.99
Rel. Volume?0.00x
Bid / Ask
Bid?$1.71 × 100
Ask?$2.33 × 100
Spread?$0.62
Midpoint?$2.02
Valuation & Ratios
Market Cap?67.0M
Shares Out?33.4M
Float?25.5M
Float %?76.4%
P/E Ratio?0.65
P/B Ratio?0.41
EPS?$3.10
Dividend?0.50%
Ex-Dividend?N/A
News
Profile
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Employees
78
Market Cap
63.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2011-11-17
Address
1111 KANE CONCOURSE
BAY HARBOR ISLANDS, FL 33154
Phone: 781-652-4500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
0
Momentum?
33
Short Sent.?
19
Piotroski F-Score?5/9Mixed
Altman Z-Score?-1.77Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?18.09%High
Short Interest?4.6M
Days to Cover?23.6
Free Float25.5M
Avg Daily Volume195.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?3.96Strong
Quick Ratio?3.83Strong
Cash Ratio?3.17Strong
Debt/Equity?0.24Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
0.7CHEAP▾
P/B?
Peers
100
S&P
97
0.41CHEAP▾
P/S?
Peers
100
S&P
87
0.96CHEAP▾
P/FCF?
Peers
100
S&P
97
0.5CHEAP▾
EV/EBITDA?
Peers
100
S&P
97
3.8CHEAP▾
EV/Sales?
S&P
97
-1.29CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
93
63.0%STRONG▾
ROA?
Peers
50
S&P
97
32.6%STRONG▾
Cash Flow & Enterprise
FCF?$125.8M
Enterprise Value?$-89938504
Fundamentals ratios updated end of day